Pozen, Inc. v. Actavis Laboratories FL, Inc. > Documents

Date Field	Doc. No.	Description (Pages)
Mar 5, 2018	3	ORDER granting motion to terminate appeal [502609-2] filed by Appellees Actavis Pharma, Inc., Actavis Laboratories FL, Inc. and Appellants Horizon Pharma, Inc., Pozen, Inc. and Horizon Pharma USA, Inc.; issuing mandate. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [502656] [17-1604, 17-1605, 17-1606, 17-1607, 17-1608, 17-1610, 17-1611, 17-1612, 17-1613, 17-1614, 17-1615, 17-1616] [SJ] [Entered: 03/05/2018 04:15 PM] (2)
Feb 9, 2017	1	Appeal docketed. Received: 02/09/2017. [406098]. [JCA] [Entered: 02/09/2017 02:57 PM] (30)
Feb 9, 2017	2	Note to file: The following cases are associated:17-1604 Lead with 17-1605, 17-1606, 17-1607, 17-1608, 17-1610, 17-1611, 17-1612, 17-1613, 17-1614, 17-1615, 17-1616 Consolidated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [406143] [17-1604, 17-1605, 17-1606, 17-1607, 17-1608, 17-1610, 17-1611, 17-1612, 17-1613, 17-1614, 17-1615, 17-1616] [JCA] [Entered: 02/09/2017 03:45 PM] (0)